Source: Simply Better Brands Corp.
  • Simply Better Brands Corp. (SBBC) has completed the second tranche of a non-brokered private placement for gross proceeds of $1,018,999.62
  • Under the second tranche, Simply Better Brands issued 3,454,236 common shares
  • The second tranche is part of a larger private placement of up to 11,016,949 common shares for total gross proceeds of up to $3,250,000
  • Simply Better Brands Corp. leads an omni-channel platform with diversified assets in the emerging plant-based and holistic wellness consumer product categories
  • Simply Better Brands Corp. opened trading at $0.38 per share

Simply Better Brands (SBBC) has closed the second tranche of a non-brokered private placement for gross proceeds of $1,018,999.62.

Under the second tranche, the company issued 3,454,236 common ‎shares for $0.295 per share.

The second tranche is part of a ‎larger private placement offering of up to 11,016,949 common ‎shares for total gross proceeds of up to $3,250,000.‎

The common shares issued in connection with the second tranche are ‎subject to a hold period that expires on December 18, 2022.‎

The company plans to use the proceeds from the second tranche to reduce debt and for general working capital purposes.

Simply Better Brands Corp. leads an international omni-channel platform with diversified assets in the emerging plant-based and holistic wellness consumer product categories.

Simply Better Brands Corp. opened trading at $0.38 per share.


More From The Market Online

“Paw Patrol” owners see a 52-week share price high

Spin Master (TSX:TOY) reported 8.9 per cent revenue growth to US$436.4 million and returned to profitability.

Uber Eats expands grocery delivery network with new U.S. regional retail partners

Uber (NYSE:UBER) Eats added Busch’s Fresh Food Market, Hays, and Lowe’s Market to its grocery delivery marketplace across the U.S.

Cybersecurity stocks worth watching as digital risks continue to evolve

Cybersecurity threats continue to evolve, while recent disruptions highlighted the importance of resilient digital infrastructure.

A small-cap contender looking to challenge the weight-loss drug giants

Structure Therapeutics (NASDAQ:GPCR) is developing an oral weight-loss pill that could offer an alternative to popular injectable treatments.